Updated: Dec 23, 2008
Adult polycystic kidney disease, which affects approximately 1 in 1000 people, is transmitted as an autosomal dominant trait. Cysts arise from the nephrons and collecting tubules; microdissection reveals that the cysts communicate directly with the nephrons and collecting tubules. Islands of normal parenchymal renal tissue are interspaced between the cysts.
Patients present with hypertension and progressive renal failure after their third decade of life. Autosomal dominant polycystic kidney disease (ADPKD) is uncommon in children and is rarely seen in neonates. From 29% to 73% of patients with the disorder have associated hepatic cysts, 9% have associated pancreatic cysts, and 5% have associated splenic cysts; pulmonary cysts occur but are uncommon. These extrarenal manifestations are not found in neonates and children.1,2,3,4,5,6,7,8
For excellent patient education resources, visit eMedicine's Kidneys and Urinary System Center. Also, see eMedicine's patient education article Blood in the Urine.
Related eMedicine topics:
Cystic Diseases of the Kidney (Urology)
Polycystic Kidney Disease
Polycystic Kidney Disease (Pediatrics)
Autosomal dominant polycystic kidney disease is an inherited condition comprising at least 3 phenotypically indistinguishable but genetically distinct entities.9,10 The specific form that develops depends on which of 3 genes— PKD1, PKD2, or PKD3 —becomes mutated.11,12 In 90% of patients, the affected gene is located on chromosome arm 16p; in 10% of patients, the disease arises from a spontaneous mutation.13 ADPKD is transmitted as an autosomal dominant trait, with almost 100% penetrance if patients live long enough. Because of the condition's variable expressivity and the incidence of spontaneous mutation, nearly 50% of patients have no family history of the disease. Defective polycystins appear to contribute to cyst formation by affecting epithelial cell maturation, resulting in the development of cysts of varying sizes in the cortex and medulla.14,15,6 An association with tuberous sclerosis complex has been described.16
Histologically, ADPKD is characterized by an abnormal rate of tubule divisions, with hypoplasia of portions of tubules left behind as the ureteral bud advances. Cystic dilatation occurs in the Bowman capsule, loop of Henle, and proximal convoluted tubule, interspersed with normal renal tissue. Thus, in contrast to fluid from simple renal cysts, which is biochemically similar to plasma, the biochemical features of the fluid content of ADPKD cysts are closer to those of urine, particularly in samples that are taken from distal nephrogenic cysts. Cysts in ADPKD are lined with flattened or cuboidal epithelium. Stromal changes are those of renal failure and are nonspecific; dystrophic calcification is common.17
With minimal disease, the kidneys are smooth and of normal size; the cysts are discovered only on cut pathologic specimens. As the size of cysts increases, the kidneys enlarge, often asymmetrically, and may become bosselated and lose their reniform shape. The age of patients at onset of cyst formation varies; 54% of cysts appear by the first decade of life, 72% by the second decade, and 86% by the third decade.18 By the age of 80 years, evidence of cyst formation exists in all persons who have the gene.19
True unilateral ADPKD is rare. (Most genetic diseases involving paired organs are bilateral.) Segmental ADPKD also is uncommon; some investigators, in fact, doubt the existence of the segmental form and suggest that it should not be considered a forme fruste of ADPKD. Segmental disease is neither inherited nor associated with renal failure. Rarely, ADPKD may be detected in utero, usually in the third trimester, although the earliest diagnosis recorded was at 14 weeks' gestation.
With small cysts, ADPKD can be confused with autosomal recessive polycystic kidney disease (ARPKD) because the kidneys may be enlarged and echogenic. Sometimes, the cortical cysts are large enough to be found on ultrasonographic images, which can confirm the diagnosis when cysts are demonstrated in the fetus of a parent with the disease.
As ADPKD progresses, impaired renal function ensues. Hypertension precedes renal failure. Extrarenal manifestations include liver cysts in 29-73% of patients, pancreatic cysts in 9%, and splenic cysts in 5%. Cysts have also been reported in the thyroid, parathyroid, lung, brain, pituitary gland, pineal gland, ovary, uterus, testis, seminal vesicles, epididymis, bladder, and peritoneum. Aneurysms of cerebral arteries (berry aneurysms) have been found in 3-50% of patients. A variety of cardiac and aortic abnormalities have been associated with ADPKD, including aortic root dilatation, aortic regurgitation, bicuspid aortic valves, coarctation of the aorta, mitral regurgitation, and abdominal aortic aneurysm.20,21
Cysts vary in size from barely visible to several centimeters in diameter. They usually contain clear, straw-colored fluid, but hemorrhage into 1 or more cysts is common, which may change the fluid's gross, biochemical, and histologic character. Cysts can become infected, and aspiration of the fluid may reveal purulent contents. Incidence of renal cell carcinoma is only slightly increased in patients with ADPKD; a greater rise in incidence is associated with cystic disease of dialysis.
Approximately 50 cases of renal cell carcinoma have been reported in association with polycystic kidneys; some of the cases were associated with von Hippel–Lindau disease and tuberous sclerosis.22 No correlation exists between the severity of renal disease and the number of liver cysts. Liver function usually remains normal in ADPKD, but with longer survival of patients with ADPKD, liver function abnormalities may occur, particularly in individuals with portal hypertension. An association between ADPKD and congenital hepatic fibrosis has been described.23
One in 1000 people carry the trait for autosomal dominant polycystic kidney disease, making it the most common genetically linked renal disorder. There are 200,000-400,000 persons with ADPKD in the United States, with approximately 6000 new cases occurring each year. About 10-12% of patients receiving maintenance hemodialysis have ADPKD.
To the authors' knowledge, no accurate figures are available regarding the international incidence and prevalence of autosomal dominant polycystic kidney disease.
No race predilection for autosomal dominant polycystic kidney disease exists.
No sex preponderance for autosomal dominant polycystic kidney disease exists.
Patients of any age can be affected with autosomal dominant polycystic kidney disease, but the mean age at diagnosis is 43 years. In rare cases, renal cysts are incidentally discovered in people aged 70-90 years.
Renal failure ultimately occurs in most patients by age 60 years. Persons may present with fever, dysuria, and leukocytosis as a result of urinary tract infections. Renal and/or ureteric colic from calculi is a known complication. Hemorrhage, which can be intracystic or retroperitoneal, may present with hematuria, abdominal pain, and, rarely, massive hemorrhagic shock or anemia. Polycythemia is a rare, but known, association secondary to increased erythropoietin production. Rarely, intracystic hemorrhage within a liver cyst may cause acute abdominal pain, mimicking acute cholecystitis. Urinalysis may reveal proteinuria and hematuria.
Seminal tract cysts are seen in 43.5% of patients with ADPKD; however, this finding does not correlate with sperm abnormalities, which are also a frequent finding, especially asthenozoospermia. This semen abnormality is probably related to the abnormal function of polycystins. Thus, the reproductive aspects of patients with ADPKD need early evaluation before the ability to conceive is further impaired by uremia.24
Computed tomography (CT) scanning is as sensitive as ultrasound in the detection of cystic disease, although problems may arise with smaller cysts. CT scanning appears to be more specific than sonography in differentiating an obstructed renal pelvis from a parapelvic cyst. It also seems to be superior to ultrasonographic images in helping assess retroperitoneal rupture of a cyst and perinephric extension of blood or pus from an infected cyst.25,26
Magnetic resonance imaging (MRI) is especially useful for examining patients who are allergic to iodinated contrast media and those with compromised renal function who are at risk for iodinated contrast – induced renal failure. MRI also has advantages for patients in whom hemorrhagic cysts are considered and is probably superior to other modalities in characterizing complicated cysts.
The role of angiography in the diagnosis of ADPKD is limited. Although angiography has a high degree of accuracy in diagnosing ADPKD, its specificity is low.
Radionuclide studies have a complementary role in the assessment of renal function in ADPKD. These studies do not have the added hazard of patient exposure to iodinated contrast material.
Nephromegaly, which can be detected on plain radiographs, may result from causes other than autosomal dominant polycystic kidney disease. Similarly, curvilinear calcification is not specific for ADPKD and may be found in other types of cysts, as well as in tumors and granulomas. Simple renal cysts with nongenetic origins may be similar to ADPKD lesions. Also, cysts associated with ADPKD cannot always be differentiated from multiple simple cysts and cysts associated with von Hippel – Lindau disease or tuberous sclerosis. Such findings apply to intravenous urography, ultrasonography, CT scanning, MRI, and angiography.
Autosomal Recessive Polycystic Kidney
Disease
Kidney, Lymphoma
Multilocular Cystic Nephroma
Tuberous Sclerosis
Von Hippel-Lindau Syndrome
Any cause of multiple intrarenal fluid collections
Hydrocalycosis, particularly if the renal pelvis is not dilated
Multiple hypoechoic and/or anechoic nodes (eg, lymphoma)
Acquired renal cystic disease
Plain abdominal radiographs have low specificity and generally are not recommended in the workup of patients with autosomal dominant polycystic kidney disease. In earlier studies on young children, intravenous urography and nephrotomography were shown to be slightly more sensitive than ultrasonography; however, ultrasonographic technology has improved tremendously, and, with state-of-the-art sonographic machines, cysts that are a few millimeters in size can be depicted. Differentiating between multiple simple renal cysts and the cysts of ADPKD may be difficult with intravenous urography.
Detectable on plain radiographs, nephromegaly may result from causes other than autosomal dominant polycystic kidney disease. Similarly, curvilinear calcification may occur in simple renal cysts and tumors. Simple renal cysts with nongenetic origins can resemble ADPKD cysts, as can lesions arising from von Hippel – Lindau disease or tuberous sclerosis.
CT scanning is a sensitive modality for examining cystic kidney disease; however, problems may arise with smaller cysts, which may not be easily differentiated from small, solid masses. Occasionally, differentiation of chronically infected cysts from a necrotic tumor also may be difficult. CT scanning appears to be more specific than sonography in differentiating an obstructed renal pelvis from a parapelvic cyst on the basis of contrast excretion pattern. It is also useful in helping assess retroperitoneal rupture of a cyst and perinephric extension of blood or pus from an infected cyst.
As with images derived from intravenous urography, CT scans of lesions associated with autosomal dominant polycystic kidney disease can resemble those of simple renal cysts of nongenetic etiology, as well as CT scans of cysts associated with either von Hippel–Lindau disease or tuberous sclerosis.
MRI of the kidneys is becoming a useful technique for characterization of renal masses and can be used in addition to or instead of CT. MRI is especially useful in patients who are allergic to iodinated contrast media and in those with compromised renal function who are at risk for iodinated contrast–induced renal failure. MRI has the added advantage of multiplanar imaging and does not require the use of ionizing radiation. Moreover, MRI is probably superior to other modalities in characterizing complicated cysts.
As with images derived from intravenous urography and CT scanning, MRI scans of simple renal cysts of nongenetic etiology, as well as those of cysts associated with either von Hippel–Lindau disease or tuberous sclerosis, can resemble scans of lesions associated with autosomal dominant polycystic kidney disease.
Sonography is a valuable screening test for patients in whom polycystic disease is suspected.
Ultrasonography is the procedure of choice in the workup of patients with autosomal dominant polycystic kidney disease. It is also an ideal modality for screening the family of patients with known disease and for routine follow-up monitoring of patients. Gardner and Evan have shown that individuals older than 40 years with a family history of ADPKD but without renal cysts are unlikely to develop the disease.27 Others have shown that when screening for evidence of ADPKD, if the kidney shows no signs of cysts or parenchymal abnormality in a patient by 19 years of age, that individual is extremely unlikely to be affected.
Renal cysts similar to those associated with autosomal dominant polycystic kidney disease can occur as simple renal cysts without genetic etiology or can arise in von Hippel–Lindau disease, in acquired uremic cystic disease (in which kidneys are small with no renal function), in patients on hemodialysis, or in patients who have had renal transplantation. In ARPKD, the kidneys are hyperechoic and enlarged, but the cysts are too small to be depicted on ultrasonographic images; however, discrete macroscopic cysts (usually <1 cm) occasionally are seen in patients with ARPKD.
Technetium-99m mercaptotriglycylglycine or other radionuclides are employed in isotope renography, which is a useful procedure for assessing renal function and avoiding the nephrotoxic effects of iodinated contrast media. On analog images, cysts are demonstrated as photon-deficient masses. Similarly, uptake of technetium-99m dimercaptosuccinic acid shows the cysts as multiple photon-deficient masses. Hepatic and splenic cysts also are photopenic on scans using technetium-99m sulfur colloid. Infected cysts, when scanned with granulocytes labeled with technetium-99m hexamethylpropyleneamine oxime, may demonstrate increased activity. Similarly, they may be avid for gallium-67 citrate.
Although isotopic renography is an excellent modality for assessing absolute and relative renal function, its role in the diagnosis of autosomal dominant polycystic kidney disease is limited.
Multiple photon-deficient renal masses may occur with simple cysts, granulomas, abscesses, and multiple tumors.
Angiographic criteria for cystic renal disease are well established. In the arterial phase, intrarenal arterial branches are stretched and displaced around the cysts. The cysts are seen as sharply defined, radiolucent masses. The cyst walls appear thin and smooth, and an acute angle is characteristic between the cyst and the normal renal cortex, forming a beak. In the nephrogram phase, avascular areas of varying sizes are demonstrated, giving rise to a Swiss cheese appearance, as on an intravenous urogram. Hemorrhagic and infected cysts may have abnormal vessels simulating the neovascularity of a neoplasm. Hepatic and splenic cysts appear as avascular masses on a flush aortogram or on selective visceral angiography.
Angiography has a high degree of sensitivity in the diagnosis of autosomal dominant polycystic kidney disease, but its specificity is low.
Differentiation from simple renal cysts is not always possible; avascular tumors also may pose problems. Renal sinus fibrolipomatosis may superficially resemble cysts associated with autosomal dominant polycystic kidney disease.
Image-guided aspiration of a cyst in which infection is suspected may confirm the diagnosis of autosomal dominant polycystic kidney disease, provide tissue for culture and sensitivity, and eventually provide a route for percutaneous drainage. Large uninfected cysts causing pressure effects also can be aspirated. Transcatheter embolization may be considered for a ruptured cyst with active bleeding.
Higashihara E, Aso Y, Shimazaki J, Ito H, Koiso K, Sakai O. Clinical aspects of polycystic kidney disease. J Urol. Feb 1992;147(2):329-32. [Medline].
Itai Y, Ebihara R, Eguchi N, Saida Y, Kurosaki Y, Minami M, et al. Hepatobiliary cysts in patients with autosomal dominant polycystic kidney disease: prevalence and CT findings. AJR Am J Roentgenol. Feb 1995;164(2):339-42. [Medline].
Kaplan BS, Kaplan P, Rosenberg HK, et al. Polycystic kidney diseases in childhood. J Pediatr. Dec 1989;115(6):867-80. [Medline].
Milutinovic J, Fialkow PJ, Rudd TG, et al. Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med. May 1980;68(5):741-4. [Medline].
Parfrey PS, Bear JC, Morgan J, et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med. Oct 18 1990;323(16):1085-90. [Medline].
Pei Y, He N, Wang K, Kasenda M, Paterson AD, Chan G, et al. A spectrum of mutations in the polycystic kidney disease-2 (PKD2) gene from eight Canadian kindreds. J Am Soc Nephrol. Oct 1998;9(10):1853-60. [Medline].
Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol. Jan 2006;13(1):26-56. [Medline].
Masoumi A, Reed-Gitomer B, Kelleher C, Bekheirnia MR, Schrier RW. Developments in the management of autosomal dominant polycystic kidney disease. Ther Clin Risk Manag. Apr 2008;4(2):393-407. [Medline].
Rohatgi R. Clinical manifestations of hereditary cystic kidney disease. Front Biosci. May 1 2008;13:4175-97. [Medline].
Torres VE, Rossetti S, Harris PC. Update on autosomal dominant polycystic kidney disease. Minerva Med. Dec 2007;98(6):669-91. [Medline].
Ariyurek Y, Lantinga-van Leeuwen I, Spruit L, et al. Large deletions in the polycystic kidney disease 1 (PKD1) gene. Hum Mutat. Jan 2004;23(1):99. [Medline].
Pei Y. Diagnostic approach in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. Sep 2006;1(5):1108-14. [Medline].
Auranen M, Ala-Mello S, Turunen JA, Jarvela I. Further evidence for linkage of autosomal-dominant medullary cystic kidney disease on chromosome 1q21. Kidney Int. Oct 2001;60(4):1225-32. [Medline].
Deltas CC. Mutations of the human polycystic kidney disease 2 (PKD2) gene. Hum Mutat. 2001;18(1):13-24. [Medline].
Koptides M, Deltas CC. Autosomal dominant polycystic kidney disease: molecular genetics and molecular pathogenesis. Hum Genet. Aug 2000;107(2):115-26. [Medline].
Bisceglia M, Galliani C, Carosi I, Simeone A, Ben-Dor D. Tuberous Sclerosis Complex With Polycystic Kidney Disease of the Adult Type: The TSC2/ADPKD1 Contiguous Gene Syndrome. Int J Surg Pathol. Jul 8 2008;[Medline].
Meijer E, de Jong PE, Peters DJ, Gansevoort RT. Better understanding of ADPKD results in potential new treatment options: ready for the cure?. J Nephrol. Mar-Apr 2008;21(2):133-8. [Medline].
Birewar S, Zawada ET Jr. Early onset polycystic kidney disease: how early is early?. S D J Med. Nov 2003;56(11):465-8. [Medline].
Dahnert W. Radiology Review Manual. 4th ed. Baltimore, Md: Lippincott Williams & Wilkins. 1999: 782.
Nakajima F, Shibahara N, Arai M, et al. Intracranial aneurysms and autosomal dominant polycystic kidney disease: followup study by magnetic resonance angiography. J Urol. Aug 2000;164(2):311-3. [Medline].
Schievink WI, Torres VE, Piepgras DG, Wiebers DO. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. Jul 1992;3(1):88-95. [Medline].
Currie RJ, Freeman SJ, McCormick F, McGonigle RJ. Polycystic kidneys: a cautionary story. Br J Radiol. Dec 2007;80(960):e305-9. [Medline].
Gulanikar AC, Daily PP, Kilambi NK, et al. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation. Dec 27 1998;66(12):1669-72. [Medline].
Torra R, Sarquella J, Calabia J, Martí J, Ars E, Fernández-Llama P, et al. Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. May 2008;3(3):790-3. [Medline].
Antiga L, Piccinelli M, Fasolini G, Ene-Iordache B, Ondei P, Bruno S, et al. Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report. Clin J Am Soc Nephrol. Jul 2006;1(4):754-60. [Medline].
Perrone R. Imaging progression in polycystic kidney disease. N Engl J Med. May 18 2006;354(20):2181-3. [Medline].
Gardner KD Jr, Evan AP. Cystic kidneys: an enigma evolves. Am J Kidney Dis. May 1984;3(6):403-13. [Medline].
Almaden Y, Hernandez A, Torregrosa V, Canalejo A, Sabate L, Fernandez Cruz L, et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol. Oct 1998;9(10):1845-52. [Medline].
Bajwa ZH, Gupta S, Warfield CA, Steinman TI. Pain management in polycystic kidney disease. Kidney Int. Nov 2001;60(5):1631-44. [Medline].
Basaria S, Mehta NN. Renal and extrarenal autosomal dominant polycystic kidney disease. Postgrad Med J. Dec 2000;76(902):814. [Medline].
Chapman AB, Rubinstein D, Hughes R, Stears JC, Earnest MP, Johnson AM, et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. Sep 24 1992;327(13):916-20. [Medline].
Chatha RK, Johnson AM, Rothberg PG, et al. Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease. Am J Kidney Dis. Apr 2001;37(4):852-8. [Medline].
Chauveau D, Fakhouri F, Grunfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol. Sep 2000;11(9):1767-75. [Medline]. [Full Text].
Chicoskie C, Chaoui A, Kuligowska E, et al. MRI isolation of infected renal cyst in autosomal dominant polycystic kidney disease. Clin Imaging. Mar-Apr 2001;25(2):114-7. [Medline].
Fick-Brosnahan GM, Tran ZV, Johnson AM, et al. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. May 2001;59(5):1654-62. [Medline].
Grampsas SA, Chandhoke PS, Fan J, et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. Jul 2000;36(1):53-7. [Medline].
Grunfeld JP, Chauveau D, Joly D. Polycystic kidney disease: >. J Nephrol. Jul-Aug 1999;12 Suppl 2:S42-6. [Medline].
Keadle DM, Bauman JM, Billingsley JL. Nonvisualization of the liver on a Tc-99m sestamibi parathyroid scan. Clin Nucl Med. Nov 2000;25(11):921-2. [Medline].
Kondo A, Akakura K, Ito H. Assessment of renal function with color Doppler ultrasound in autosomal dominant polycystic kidney disease. Int J Urol. Mar 2001;8(3):95-8. [Medline].
Kwok CG, McDougall IR. Persistent fever in a patient with polycystic kidney and liver diseases and bilateral hip prostheses. J Nucl Med. Dec 1996;37(12):2062-5. [Medline].
Lilova MI, Petkov DL. Intracranial aneurysms in a child with autosomal recessive polycystic kidney disease. Pediatr Nephrol. Dec 2001;16(12):1030-2. [Medline].
Martignoni G, Bonetti F, Pea M, et al. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome. Am J Surg Pathol. Feb 2002;26(2):198-205. [Medline].
Milutinovic J, Agodoa LC, Cutler RE, et al. Autosomal dominant polycystic kidney disease. Early diagnosis and consideration of pathogenesis. Am J Clin Pathol. Jun 1980;73(6):740-7. [Medline].
Mizoguchi M, Tamura T, Yamaki A, et al. Genotypes of autosomal dominant polycystic kidney disease in Japanese. J Hum Genet. 2002;47(1):51-4. [Medline].
Nascimento AB, Mitchell DG, Zhang XM, et al. Rapid MR imaging detection of renal cysts: age-based standards. Radiology. Dec 2001;221(3):628-32. [Medline].
Neureiter D, Frank H, Kunzendorf U, et al. Dialysis-associated acquired cystic kidney disease imitating autosomal dominant polycystic kidney disease in a patient receiving long-term peritoneal dialysis. Nephrol Dial Transplant. Mar 2002;17(3):500-3. [Medline]. [Full Text].
Nicolau C, Torra R, Bianchi L, et al. Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound. Jul-Aug 2000;28(6):277-82. [Medline].
Roy A, Soni GR, Kolhapure RM, Banerjee K, Patki PS. Induction of tumour necrosis factor alpha in experimental animals treated with hepatotoxicants. Indian J Exp Biol. Aug 1992;30(8):696-700. [Medline].
Sise C, Kusaka M, Wetzel LH, et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int. Dec 2000;58(6):2492-501. [Medline].
Somlo S, Markowitz GS. The pathogenesis of autosomal dominant polycystic kidney disease: an update. Curr Opin Nephrol Hypertens. Jul 2000;9(4):385-94. [Medline].
autosomal dominant polycystic kidney disease, Potter type III disease, adult polycystic kidney disease, kidney disease, polycystic kidney disease, renal cyst, ADPKD, ADPCKD, renal failure, hypertension, impaired renal function, PKD1, PKD2, PKD3
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP, Chairman of Medical Imaging, Professor of Radiology, NGHA, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia
Ali Nawaz Khan, MBBS, FRCS, FRCP, FRCR, LRCP is a member of the following medical societies: American Institute of Ultrasound in Medicine, Radiological Society of North America, Royal College of Physicians, Royal College of Physicians and Surgeons of the United States, Royal College of Radiologists, and Royal College of Surgeons of England
Disclosure: Nothing to disclose.
Muthusamy Chandramohan, MBBS, DMRD, FRCR, Consultant Radiologist, Bradford Teaching Hospitals, UK
Disclosure: Nothing to disclose.
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR, Lecturer, Sheffield University Medical School; Endovascular Fellow, Sheffield Vascular Institute
Sumaira MacDonald, MBChB, PhD, MRCP, FRCR is a member of the following medical societies: British Medical Association, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.
John L Haddad, MD, Clinical Associate Professor, Department of Radiology, Weill Medical College of Cornell University; Director of Body MRI, Department of Radiology, Methodist Hospital in Houston
John L Haddad, MD is a member of the following medical societies: American College of Radiology, American Medical Association, and Radiological Society of North America
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Arnold C Friedman, MD, FACR, Associate Chairman, Department of Radiology, University of Florida Health Science Center; Chief, Department of Radiology, Shands-Jacksonville Hospital
Arnold C Friedman, MD, FACR is a member of the following medical societies: American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.
Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.
Eugene C Lin, MD, Consulting Radiologist, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)